Clinical Trial Update: Artificial Intelligence to Personalize Prostate Cancer Treatment (the HypoElect Trial) [Phase 2]

View source ↗

Summary

The HypoElect trial is a Phase 2 study evaluating AI-driven personalization of prostate cancer treatment. It is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: German Oncology Center, Cyprus | Conditions: Prostate Cancer | Phase 2 | Status: RECRUITING